Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology and Hepatology
Volume 2017, Article ID 8186275, 7 pages
https://doi.org/10.1155/2017/8186275
Research Article

Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis

1Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 211166, China
2Department of Infectious Diseases, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
3Department of Basic and Community Nursing, School of Nursing, Nanjing Medical University, Nanjing 211166, China
4Department of Infectious Diseases, The Jurong People’s Hospital, Jurong 212400, China
5Department of Epidemiology, Medical Institute of Nanjing Army, Nanjing 210002, China

Correspondence should be addressed to Peng Huang; nc.ude.umjn@gnepgnauh and Rongbin Yu; nc.ude.umjn@uynibgnor

Received 14 September 2016; Accepted 20 December 2016; Published 9 January 2017

Academic Editor: Mang Ma

Copyright © 2017 Yinan Yao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Yinan Yao, Ming Yue, Jie Wang, et al., “Grazoprevir and Elbasvir in Patients with Genotype 1 Hepatitis C Virus Infection: A Comprehensive Efficacy and Safety Analysis,” Canadian Journal of Gastroenterology and Hepatology, vol. 2017, Article ID 8186275, 7 pages, 2017. https://doi.org/10.1155/2017/8186275.